PTEN and neoplasm: As previously mentioned, one of the most commonly-modified pathways in gliomas is PI3K-PTEN-Akt, which is activated in normal and cancer cells [58] and controls tumour cell proliferation [59,60] and/or maintenance of the tumour phenotype [61].